Trademark Overview
On Thursday, November 21, 2024, a trademark application was filed for QAIALDO with the United States Patent and Trademark Office. The USPTO has given the QAIALDO trademark a serial number of 79417410. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, February 20, 2025. This trademark is owned by Nova Laboratories Ltd. The QAIALDO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Pharmaceutical preparations, namely oral liquids; pharmaceutical preparations, namely oral suspensions; pharmaceutical preparations for the treatment of heart failure; pharmaceutical preparations for treating or alleviating the symptoms of heart failure; pharmaceutical preparations for use in the management of refractory oedema; pharmaceutical preparations for use in the management of refractory oedema associated with congestive heart failure, hepatic cirrhosis, malignant ascites, nephrotic syndrome or essential hypertension; pharmaceutical preparations for oral delivery; oral liquids used for the treatment of heart failure and for other indications.
Apparatus and devices for the delivery of pharmaceutical preparations; apparatus and devices for the oral delivery of pharmaceutical preparations; oral syringes.